The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin

scientific article

The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/074873049300800303
P698PubMed publication ID8280909

P2093author name stringP Lavie
O Tzischinsky
A Shlitner
P2860cites workMelatonin shifts human circadian rhythms according to a phase-response curveQ34253161
Different types of melatonin circadian secretory rhythms in some blind subjectsQ34271484
The importance of timing in melatonin administration in a blind manQ34311751
The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod).Q43752107
Delayed sleep phase syndrome response to melatoninQ45274362
Timing of naps: effects on post-nap sleepiness levelsQ46902469
Ultrashort sleep-waking schedule. III. 'Gates' and 'forbidden zones' for sleepQ48353043
The 24-hour sleep propensity function: experimental bases for somnotypologyQ48884456
Circadian rhythms in 6-sulphatoxymelatonin and nocturnal sleep in blind childrenQ48913950
Melatonin Administration to Blind People: Phase Advances and EntrainmentQ48914251
Pineal N-acetyltransferase Activity in Blinded and Anosmic Male Rats12Q51120176
Bioavailability of oral melatonin in humans.Q52431867
P433issue3
P304page(s)199-209
P577publication date1993-01-01
P1433published inJournal of Biological RhythmsQ2093446
P1476titleThe association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin
P478volume8

Reverse relations

cites work (P2860)
Q47685588Analysis of Different Melatonin Secretion Patterns in Children With Sleep Disorders: Melatonin Secretion Patterns in Children
Q34633689Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model.
Q39190597Circadian Disruption Associated with Alzheimer's Disease
Q37495402Circadian sleep-wake rhythm disturbances in end-stage renal disease
Q21296744Clinical uses of melatonin in pediatrics
Q48747088Correlation between the circadian sleep propensity rhythm and hormonal rhythms under ultra-short sleep-wake cycle
Q25255533Daily illumination exposure and melatonin: influence of ophthalmic dysfunction and sleep duration
Q56506284Depression: chronophysiology and chronotherapy
Q48783990Disturbance of sleep in blindness
Q48778940Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.
Q34563262Effects of exercise with or without light exposure on sleep quality and hormone reponses
Q41666391Efficacy of melatonin as a hypnotic agent
Q41666388Efficacy of melatonin as a sleep-promoting agent
Q46839791Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt
Q35890534Melatonin - a chronobiotic and soporific hormone
Q47739841Melatonin and circadian rhythms in autism: Case report
Q34970081Melatonin and melatonergic drugs on sleep: possible mechanisms of action
Q41666377Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG.
Q43567911Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial
Q44025868Melatonin promotes sleep in three species of diurnal nonhuman primates
Q43623869Melatonin promotes sleep-like state in zebrafish
Q47999885Melatonin, Circadian Rhythms, and Sleep
Q41666397Melatonin: role in gating nocturnal rise in sleep propensity
Q33936320More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities
Q28394551Morning and Evening Blue-Enriched Light Exposure Alters Metabolic Function in Normal Weight Adults
Q34324919Out of the lab and into the bathroom: evening short-term exposure to conventional light suppresses melatonin and increases alertness perception
Q48100506Pharmacological characterization of M-II, the major human metabolite of ramelteon
Q33854026Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders
Q48809844Potential of Melatonin Replacement Therapy in Older Patients with Sleep Disorders
Q37004418Role of the melatonin system in the control of sleep: therapeutic implications
Q48717227Sleep and circadian phase characteristics of adolescent and young adult males in a naturalistic summertime condition
Q46636444Sleep promoters and insomnia
Q90342061Sleep-wake disturbances in hospitalized patients with traumatic brain injury: association with brain trauma but not with an abnormal melatonin circadian rhythm
Q36112393The effect of traumatic brain injury on the timing of sleep.
Q37156278The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study)
Q48768493The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55-80 years
Q35023164The relationship between the rate of melatonin excretion and sleep consolidation for locomotive engineers in natural sleep settings
Q38001806The role of melatonin in patients with chronic kidney disease undergoing haemodialysis
Q37217240The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders
Q36448238Understanding sleep-wake behavior and sleep disorders in children: the value of a model
Q37210222Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks.
Q37802476What keeps us awake? The role of clocks and hourglasses, light, and melatonin